Introduction
Hybrid coronary revascularization (HCR), which involves the combined use of percutaneous and surgical techniques, has emerged as an alternative to conventional coronary artery bypass grafting (CABG) for selected patients with multi-vessel coronary disease. [1] [2] [3] In most cases, HCR involves a surgical procedure in which the internal mammary artery (IMA) is grafted to the left anterior descending (LAD) coronary artery, preceded or followed by percutaneous coronary intervention (PCI) of non-LAD coronary lesions, either performed in one-setting (concurrent) or as a staged procedure. 4 A prerequisite for HCR is that the patient has LAD anatomy eligible for surgical revascularization, but also has non-LAD lesions that are amenable for PCI. The concept of HCR stems from the hypothesis that 1) bypass grafting of the LAD with an IMA graft is superior to coronary stenting; and 2) PCI with the latest drug-eluting stents is equal or even superior to other bypass grafts used for non-LAD disease. 5, 6 Advances in surgical techniques also allowed IMA-to-LAD grafting to be performed using lesser invasive techniques than conventional CABG. Although several reports suggested a reduction in perioperative morbidity, length of intensive care and hospital stay, with equal LIMA patency, these studies have generally been limited to a small number of high-volume centers with experienced operators. 3, 4, 7 It is unknown the degree to which HCR is used in routine clinical practice in the United States, as well as the clinical characteristics or in-hospital outcomes of patients who undergo HCR.
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Methods

Study population
From the STS adult cardiac database version 2.73 we included patients that were enrolled from July 2011 thru March 2013. From this starting population we included patients who underwent a hybrid procedure or isolated CABG, and applied a number of exclusion criteria, which are listed in Figure 1 .
Procedural definitions and outcomes
In our study, HCR was considered a planned procedure that included the use of an IMA graft and coronary stent placement that could either be performed concurrently or a two staged procedures performed during the same hospitalization. Other variable definitions followed the standards of the Society of Thoracic Surgeons Adult Cardiac Surgery Database data version 2.73
(http://www.sts.org). The primary outcome was in-hospital mortality or major morbidity, a composite of: (peri) operative mortality, need for reoperation (for bleeding/tamponade, valvular dysfunction, graft occlusion, or other cardiac reasons), stroke, renal failure, mediastinitis, or prolonged ventilation. The secondary outcomes were the individual components of the composite endpoint, and post-operative length of hospital stay.
Statistical analysis
The incidence of HCR in the study population was presented as a median, interquartile range, minimum and maximum. Variation in the incidence among U.S. hospitals was assessed by histograms, sorted from largest to smallest percentage of HCR use, to graphically display hospital variation. Temporal trends of hospital rates of HCR among the study population were n our study, HCR was considered a planned procedure that included the use of a a an n IM IM IMA A A gr gr graf af aft t an a d coronary stent placement that could either be performed concurrently or a two staged procedures pe erf rf for or orm me med d d du du during ng g t t the h same hospitalization. Other er er v va ariable definit tio io i ns f f fol ol ollo l wed the standards of 
Presenting features and clinical characteristics
The clinical characteristics are displayed in Table 1 Continuation of dual antiplatelet therapy was more frequent among patients who underwent staged or concurrent HCR, as recent use of ADP inhibitor (<5 days) was of 25.2%
and 27.0% after staged and concurrent HCR respectively, versus 11.3% in the conventional CABG group. Also the use of glycoprotein IIb/IIIa inhibitors was higher in the HCR groups compared with CABG (2.0%, 10.8% and 5.0%).
Operative characteristics
Among patients who underwent staged HCR, surgical revascularization was performed first in 540 patients (66.8%), and PCI was performed first in 269 patients (33.2%). In the concurrent HCR group, surgical revascularization also occurred first in the majority of cases (70.2%). As Cont tin in nua ua uati ti ion on on o o of f du dual al a a a ant t tip ip ipla la ate te t le e et t t th th ther er erap ap apy y y wa wa was s s mo mo ore re re f f fre re r qu qu quen en e t t t am am amon on ong g g pa pa p ti ti t en en ents ts s w w who by guest on September 16, 2017 http://circ.ahajournals.org/ Downloaded from shown in Table 2 , the operative approach in the HCR group more frequently consisted of less invasive techniques than median sternotomy compared with conventional CABG. Additionally, cardiopulmonary bypass was less commonly used in the HCR groups compared with CABG (83.4%, 45.0% and 36.9% after CABG, staged and concurrent HCR respectively). Conversion to use of cardiopulmonary bypass was similar in both groups (CABG: 0.6%, staged HCR: 0.8% and concurrent HCR: 0.0%). Also, when cardiopulmonary bypass was used, the on-pump times tended to be shorter after HCR. In all groups the use of the LIMA was primarily used alone ( 94%), but sometimes also in combination with the RIMA for complete arterial revascularization ( 5%). Robotic technology to assist in IMA harvesting was used in 33.0% and 30.5% of patients undergoing staged and concurrent HCR respetively, versus only 0.66% in the CABG group. As expected, the total number of vein grafts was higher in the CABG group (median= 2, IQR: 2-3) compared with both HCR groups (both medians equal zero, IQR: 0-2).
Procedural time, as measured by skin incision time and total time in the operating room, were shorter after staged HCR procedures compared with concurrent HCR and CABG. The use of blood products was lower after concurrent HCR compared with staged HCR as well as conventional CABG (31.4%, 28.2% and 19.9%).
In-hospital outcomes
The in-hospital outcomes are displayed as event rates and unadjusted and adjusted odds ratios in Table 3 . The composite endpoint of in-hospital mortality, stroke, reoperation, renal failure, blood produc cts ts ts w w was as as l low ow ower e a a aft ft fter e e c c con on o cu cu c rr rr ren en ent t t HC HC HCR R R co co comp mp mpar ar red ed ed w w wit it th h h st s s ag ag aged ed ed H H HCR CR CR a a as s s we we well ll ll a as HCR; although a trend towards higher mortality was observed among patients who underwent concurrent HCR (adjusted OR:2.26, 95%-CI:0.99-5.17, p=0.053). The 5 reported deaths in the concurrent HCR group were either cardiac related (n=4) or due to pulmonary causes (n=1).
Among the non-fatal endpoints, a trend towards lower risk of stroke after staged HCR was found, compared with the conventional CABG group. Post-operative length of stay tended to be shorter after concurrent HCR and CABG [median (IQR)= 5 (4-7) days versus 6 (4-7) days, p=0.101), and also after staged HCR and CABG [5 (4-7) days versus 6 (4-7) days, p=0.098).
Discussion
This study represents the first nationwide assessment of the use, characteristics and in-hospital outcomes of hybrid coronary procedures among patients with multi-vessel coronary artery disease. In contemporary practice, HCR, either performed as staged or concurrent procedures, remains uncommon, as it represents only a mere half percent of the total CABG volume.
Moreover, even among the hospitals that performed HCR (approximately one-third of all hospitals with CABG capabilities), the use of HCR was less than 1% of the total CABG volume.
The low adoption of HCR among U.S. hospitals can in part be attributed to the low use of minimally invasive surgical techniques, as hospitals that performed HCR without minimally invasive techniques were also less likely to perform HCR. Additionally, the low use of concurrent HCR is likely due to the limited availibility of hybrid operating rooms. Over a relatively short time period that we have data available (<2 years), no temporal trend could be observed for the use of HCR in current U.S. practice. Compared with CABG, patients who underwent concurrent HCR or staged HCR had higher risk profiles, but less extensive coronary disease. As expected, HCR was more frequently performed using less invasive surgical This study represents the first nationwide assessment of the use, characteristics a and nd nd i in n--ho ho hosp sp spit it ital al outcomes of hybrid coronary procedures among patients with multi-vessel coronary artery di ise se eas as ase e. e. I I In n n co co contem em mp porary practice, HCR, either pe pe perf f formed as stage ge ged or or c c co o oncurrent procedures, e em ma mains uncomm mm mo on, a a as i i it t t re re repr pr pre es esen en nts ts s o on nl nly y y a me me mere h h ha al lf pe pe per rc rce en nt t of of t th he e to tot t tal l CA CA ABG B BG v v vol ol lum um ume. . .
Mo Mo ore re reov ov over er, , , ev ev even en a am mo mong n ng t t the he h h hos os o pi pi pita ta tals ls ls t th ha hat t t pe pe perf rfor or orm me med d d HC HC HCR R R ( (a (app pp ppro ro oxi xi ima ma m t t tely ly y o on ne ne-t -t -hi hi ird rd rd of f f al l ll l f f f f hospitals with th h C C CAB AB ABG G G ca ca capa pa abi bi bili li l ti ies es es), ), t t the he u u use se se o o of f f HC HC HCR R R wa w w s s s le le less ss ss t tha ha han n n 1% % % o o of f f th th the e e to to ota ta tal l l CA CA CABG B B volume. . approaches, including minimal invasive thoracic access, use of with robotic assistance and avoidance of cardiopulmonary bypass. The use of blood products was lower after concurrent HCR compared with staged HCR as well as conventional CABG, and in-hospital outcomes were overall comparable, although operative mortality tended to be higher in the concurrent HCR compared with staged HCR and CABG.
Clinical outcomes
In the last 5 years several studies have been published on in-hospital clinical outcomes after concurrent and/or staged HCR procedures. 7, [9] [10] [11] [12] [13] [14] [15] [16] [17] In Table 4 , we have summarized the key findings from these studies. The number of patients that underwent HCR in these studies ranged from 5 to 300 patients, and most operators used a partial sternotomy or small lateral thoracotomy approach with or without the use of robotic assistance. Overall, low mortality rates are seen in studies that used minimally invasive techniques (0-1.3%), with equally low rates for stroke (0-1.0%) and reoperation for bleeding (0-4.2%). However, there was one larger study by Zhao et al populations, the overall event rates of staged HCR in our study appear to be comparable with those reported previously. However, the reported rates for in-hospital mortality and need for reoperation after concurrent HCR seem to be higher compared to prior studies. Although, speculative this may suggest that these procedures are more often used in patients populations that are at higher risk for complications, as reflected by the higher pre-operative incidence of stroke, peripheral vascular disease and renal failure.
Bleeding outcomes and the use of anticoagulants
There are concerns that HCR, particularly when performed concurrently, carries an increased bleeding risk, due to the necessity for two distinct anticoagulation protocols for the surgical and percutaneous aspects of the procedure. However, as shown in our study, the use of blood products was markedly lower in concurrent HCR group, and the need for reoperation for cardiac causes including bleeding were comparable between concurrent HCR and CABG as well as 
Hospital stay
Given the use of more minimal invasive techniques, it was anticipated that postoperative hospital length of stay would be shorter in patients that underwent one-stage HCR versus CABG. In other studies the average hospital stay for one-stage HCR ranged from approximately 4 to 8 days (see Table 4 ). Among studies that compared intensive care and postoperative hospital length of stay between one-stage HCR and conventional CABG, both time of recovery at the intensive care and percutaneous aspects of the procedure. However, as shown in our study, the use o of of b b blo o ood od od products was markedly lower in concurrent HCR group, and the need for reoperation for cardiac ca aus us uses es s i i inc nc clu lu ludi d d ng g b b ble leeding were comparable betw w wee een n concurrent H H HCR R a a an nd nd CABG as well as t tag g ged e HCR a and nd d C C CAB AB BG, G, , d d des es espi pi pite te t t the he he h hig igh her r ra rat tes of of of rec c cen en nt t AD AD ADP P in inhi hibi bi it t tor r us us se e, e, a as s we w well ll l a a as gl glyc yc ycop op opro rote tein in in I IIb Ib/ / /II II Ia a i in nh hi hibi bito o or rs r a a am m mon o ong g HC HC HCR R R pa pa ati ti t e en ent ts s. Ne Ne New w w an an nti ti tipl pl lat t tel el elet et ag ge gent nt nts, s, s s s suc uc ch h h as t t the he e d di ir rec ec ct t hrombin inh hib ib bit it tor or r b b biv iv val al lirud ud udin in in, ha ha have ve ve b bee ee een n n pr pr prop op opos os o ed ed ed a a as s a a a si si sing ng ngle le le a a ant n n ic c coa oa oagu gu gula la lant nt n i in n n HC HC HCR R R ca c ses to d d time to discharge were shorter in the HCR group 3, 9, 13 . In our study, post-surgery length of hospital stay tended to be shorter after HCR compared with CABG, but did not reach statistical significance. A number of reasons may be attributable to this finding: 1) the use of minimal invasive techniques was lower in our cohort than in others; 2) HCR ocurred in a more heterogenous (and generally sicker) patient population; 3) HCR procedures performed do not only represent those performed by high-volume operators in specialized HCR centers but instead present an overall experience among U.S. hospitals.
Decision making process: HCR vs. CABG
In our study, data were not collected on why surgeons and cardiologists opted for HCR instead of conventional CABG or multi-vessel PCI. Other studies, also seldomly provided data on why HCR was performed instead of CABG. In an attempt to assess this, Zhao et al 11 retrospectively
showed that in the majority of cases, HCR was preferred over CABG to either minimize surgical risk (47.8%) or because of ungraftable vessels (43.3%). Given the differences in clinical and procedural characteristics in our study, we speculate that similar reasons may have been involved in the decision making for performing HCR in our study population. Additionally, our study showed that centers that have experience with less invasive CABG techniques also are also more likely to adopt HCR as a revascularization strategy for patients with multi-vessel coronary disease.
Defining hybrid procedures
Ever since the first publication on combined use of surgical and percutaneous techniques for h how ow owed ed ed t t tha ha hat t t i in in t the he he m majority of cases, HCR was pr pr pref f fe f rred over CA A ABG BG t t to o o e either minimize surgical i i isk k k ( (47.8%) o or r b be b ca cau us se of of of u ung ng ngra raft ft ftab ab ble le e v v vesse e els s s (43 3 3.3 3% 3%). ). ). G Giv iv ve en n t th he he d dif if ffe fe f r re enc nc ces es s i in n cl cl c in in inic i ical l a and d nd pr proc oc oced ed edur ural al c c cha h hara ra act ct ter eris is st tic cs cs i in ou ou o r r r st st stud ud u y, y, , w w we e e s sp spec ec ecul ul la at te e t tha ha hat t t si si simi mi ila la l r r r re e eas as ason on ns s ma ma ay y y ha ha h ve ve ve b b bee e en in inv vo volv lv ved e n the decisio on n n ma ma maki ki king ng ng f f for r p p per er erfo o orm rm rmin in ing HC HC HCR R R in in in o o our ur ur s stu tu t dy dy y p p pop op opul ul ulat at atio i n. n. n Ad Ad Addi di diti ti tion on nal al ally ly ly, , ou ou our r study one hospitalization, in a broad population and without restriction on surgical techniques used. In prior single center registries that reported outcomes on HCR, more stringent definitions have been used, which may explain some of the difference between these observations and our own. A more standardized definition for HCR, as recently proposed, may therefore be helpful to compare outcomes between various studies.
19
Limitations
There are a number of limitations of the current study. First, the current analysis involves registry data that due to its non-randomized nature is by definition biased. Second, although we adjusted properly for known/measured confounding, unmeasured confounding is still present.
Third, although this study represents the largest cohort of HCR patients to date, the sample size as well as the number of events are small, and inferences on in-hospital outcomes should therefore be done with caution. Fourth, although the STS database collects information on hybrid procedures, it only captures information on patients that survived at least the first stage of a hybrid procedure. As such information on intention to treat was not available. Although this poses a limitation for concurrent HCR cases, it poses an even greater challenge for patients who underwent staged HCR due to concerns of survival bias. Fifth, due to the inherent limitation of the STS data collection form, which only collects information on procedures performed during one hospitalization, staged HCR procedures in which the two stages are not performed within the same hospitalization or center, were not captured. As such, the number of staged HCR procedures is underreported in the STS database. Sixth, for the current analysis only "planned" HCR cases were considered, and "unplanned" HCR were excluded. Although the STS states
clear definitions for what is considered "planned" and "unplanned", data managers might have misclassified patients. Seventh, due to the limitations of the STS data collection form, we could Third, although this study represents the largest cohort of HCR patients to date, th th he e sa samp mp mple le le s s si iz ize as well as the number of events are small, and inferences on in-hospital outcomes should h her er ref ef efo or ore e be be be d d don ne e e w w with caution. Fourth, although h h t th he e STS databas se e e coll ll lec ec ects t information on hybrid proc c ced e ures, it o onl n n y y y ca cap pt p u ur ures es es i i inf nf nfor orma ma mati t o on on on pa pa atien n nts s s th hat at at s sur ur rv vi ive ved d at at l lea ea ast t t the he he f f fir irst st t sta ta tage ge e o o of f f a a hy hybr br b id id id p p pro roce ce ced du dure re e. As As A s su uc ch h in n nfo fo form rm rmat at ati io ion n n on on on i i in n nten en enti tion on on to o o tr r rea ea eat t t wa wa was s no no ot t t av av vai ail la labl bl le. e. e A A Alt lt tho ho houg ug gh th this is s poses a limita ta ati ti tion on o f f for or o c c con o o cu cu urr rr rren en nt t t HC HC HCR R ca ca case se s s, s, s i i it t po po pose se ses s s an n n e e eve ve ven n n gr gr grea e e te te ter r ch ch chal al alle le leng ng ge e e fo fo for r r pa pa patients who by guest on September 16, 2017 http://circ.ahajournals.org/ Downloaded from not assess detailed information on percutaneous coronary intervention, including the location and length of the treated lesion, stent (type) use, and residual stenosis. Hence we could not quantify which vessels were revascularized using percutaneous and which by surgical means. Finally, information on long-term clinical outcomes, (including cardiac death, non-fatal myocardial infarction and need for repeat revasclarization) could not be assessed, which is of major importance when assessing the efficacy of HCR as an alternative approach to surgical coronary revascularization. Displayed are the event rates for in-hospital outcomes, as well as odds ratios (OR) and 95% confidence interval (CI) using the isolated CABG group as a reference ( §, ¶ ). * For the composite outcome and operative mortality, the OR and 95%CI were adjusted for differences in baseline risk, for the remaining, nonfatal outcomes unadjusted ORs are presented 1. Among patients without previous renal failure. ** ORs could not be calculated as there is no event for the outcome of interest in at least one of the comparison groups. 
Conclusions
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